Ascendis Pharma A (ASND) Construction in Progress (2019 - 2021)

Ascendis Pharma A has reported Construction in Progress for 3 years, with the latest figure at $2173.5 in Q4 2021.

• Quarterly Construction in Progress fell 20.74% year-over-year to $2173.5 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was $2173.5 (down 20.74% YoY) and the FY2021 annual result came in at $2173.5, down 20.74% from the prior year.
• Construction in Progress retreated to $2173.5 in Q4 2021 per ASND's latest filing, from $2742.3 in the prior quarter.
• Over five years, Construction in Progress peaked at $3.0 million in Q4 2019 and troughed at $2173.5 in Q4 2021.
• A 3-year average of $997837.5 and a median of $2742.3 in 2020 frame the typical range for Construction in Progress.
• The sharpest annual moves came in 2020 and 2021: Construction in Progress plunged 99.91% in 2020, then retreated 20.74% in 2021.
• Over 3 years, Construction in Progress stood at $3.0 million in 2019, then slumped by 99.91% to $2742.3 in 2020, then dropped by 20.74% to $2173.5 in 2021.
• According to Business Quant data, Construction in Progress over the past three periods registered $2173.5, $2742.3, and $3.0 million for Q4 2021, Q4 2020, and Q4 2019 respectively.